{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-106651","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2026-10-05T12:00:38+00:00","discovered_at":"2026-10-05T12:05:00.290216+00:00","generated_at":"2026-10-12T14:44:38.457107+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Jasper Therapeutics holders approve 1-for-15 to 1-for-35 reverse split and share increase to 675M","bullets":["Proposal 1 approved 21,088,353 to 567,692 (91,820 abstentions): reverse stock split at a ratio of 1-for-15 to 1-for-35, at Board discretion any time on or before December 31, 2026.","Proposal 2 approved 20,722,644 to 903,655 (121,566 abstentions): authorized common stock rises from 490,000,000 to 675,000,000 shares, effected at Board discretion.","Proposal 3 (adjournment if needed) approved 20,938,915 to 528,123 (280,827 abstentions); all three proposals passed at the September 30, 2026 special meeting.","21,747,865 shares, roughly 65.36% of the 33,274,561 shares outstanding on the August 10, 2026 record date, were represented virtually or by proxy.","Proposals were detailed in the definitive proxy statement filed with the SEC on September 4, 2026; split would not reduce the authorized share count."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-106651","json":"https://secwatch.observer/filing/0001213900-26-106651.json","markdown":"https://secwatch.observer/filing/0001213900-26-106651.md","text":"https://secwatch.observer/filing/0001213900-26-106651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026106651/0001213900-26-106651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026106651/ea0307484-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:44:38.457107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}